These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 22099793)

  • 21. The impact of recombinant human growth hormone treatment during chronic renal insufficiency on renal transplant recipients.
    Fine RN; Sullivan EK; Kuntze J; Blethen S; Kohaut E
    J Pediatr; 2000 Mar; 136(3):376-82. PubMed ID: 10700696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applying the Growth Failure in CKD Consensus Conference: evaluation and treatment algorithm in children with chronic kidney disease.
    Mahan JD
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S68-78. PubMed ID: 16750646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS.
    Fine RN; Stablein D; Cohen AH; Tejani A; Kohaut E
    Kidney Int; 2002 Aug; 62(2):688-96. PubMed ID: 12110034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment with recombinant human growth hormone (rhGH) in children with chronic kidney failure or renal transplantation].
    Crosnier H; Guest G; Souberbielle JC; Broyer M; Rappaport R
    Arch Pediatr; 1994 Aug; 1(8):716-22. PubMed ID: 7842104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal analysis of T-helper cell phenotypes in renal-transplant recipients undergoing growth hormone therapy.
    Melk A; Daniel V; Mehls O; Opelz G; Tönshoff B
    Transplantation; 2004 Dec; 78(12):1792-801. PubMed ID: 15614153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with recombinant human growth hormone in short children with nephropathic cystinosis: no evidence for increased deterioration rate of renal function. The European Study Group on Growth Hormone Treatment in Short Children with Nephropathic Cystinosis.
    Wühl E; Haffner D; Gretz N; Offner G; van't Hoff WG; Broyer M; Mehls O
    Pediatr Res; 1998 Apr; 43(4 Pt 1):484-8. PubMed ID: 9545002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of rhGH in children with chronic kidney disease: lessons from NAPRTCS.
    Seikaly MG; Salhab N; Warady BA; Stablein D
    Pediatr Nephrol; 2007 Aug; 22(8):1195-204. PubMed ID: 17530299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of rhGH treatment on final height of renal-transplant recipients in childhood.
    Gil S; Vaiani E; Guercio G; Ciaccio M; Turconi A; Delgado N; Rivarola MA; Belgorosky A
    Pediatr Nephrol; 2012 Jun; 27(6):1005-9. PubMed ID: 22278170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone treatment improves final height and nutritional status of children with chronic kidney disease and growth deceleration.
    Bizzarri C; Lonero A; Delvecchio M; Cavallo L; Faienza MF; Giordano M; Dello Strologo L; Cappa M
    J Endocrinol Invest; 2018 Mar; 41(3):325-331. PubMed ID: 28819753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry.
    Fine RN; Stablein D
    Pediatr Nephrol; 2005 Mar; 20(3):404-8. PubMed ID: 15682317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting growth and strategies for treatment in children after renal transplantation.
    Tönshoff B; Mehls O
    Pediatr Transplant; 1997 Nov; 1(2):176-82. PubMed ID: 10084778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term recombinant human growth hormone use in Australian children with renal disease.
    Crompton CH;
    Nephrology (Carlton); 2004 Oct; 9(5):325-30. PubMed ID: 15504147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Results of treatment with recombinant human growth hormone in children with growth retardation in end-stage renal disease].
    Sieniawska M; Pańczyk-Tomaszewska M; Ziółkowska H; Jedrzejowski A; Leszczyńska B; Dyras P; Kałuzyńska A; Makulska I; Pietrzyk JA; Rubik J; Siteń G; Stachowski J; Szprynger K; Zurowska A; Roszkowska-Blaim M
    Pol Merkur Lekarski; 2001 Apr; 10(58):263-6. PubMed ID: 11434172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone therapy in children with CKD after more than two decades of practice.
    Rees L
    Pediatr Nephrol; 2016 Sep; 31(9):1421-35. PubMed ID: 26369925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of growth hormone treatment in short children with renal allografts: three year experience. Members of the German Study Group for Growth Hormone Treatment in Children with Renal Allografts.
    Tönshoff B; Haffner D; Mehls O; Dietz M; Ruder H; Blum WF; Heinrich U; Stöver B
    Kidney Int; 1993 Jul; 44(1):199-207. PubMed ID: 7689125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human growth hormone (rhGH) is effective in pubertal patients.
    Hokken-Koelega AC
    Br J Clin Pract Suppl; 1996 Aug; 85():12-3. PubMed ID: 8995020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant growth hormone use pretransplant and risk for post-transplant lymphoproliferative disease--a report of the NAPRTCS.
    Dharnidharka VR; Talley LI; Martz KL; Stablein DM; Fine RN
    Pediatr Transplant; 2008 Sep; 12(6):689-95. PubMed ID: 18179637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone treatment in children before and after renal transplantation.
    Hokken-Koelega AC
    J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():359-64. PubMed ID: 8887181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The causes of the end of growth hormone treatment in children with chronic renal failure].
    Leszczyńiska B; Ziółkowska H; Majcher A; Roszkowska-Blaim M
    Przegl Lek; 2006; 63 Suppl 3():153-5. PubMed ID: 16898517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Summary of Expert Opinion on the Management of Children With Chronic Kidney Disease and Growth Failure With Human Growth Hormone.
    Cappa M; Maghnie M; Carbone V; Chioma L; Errichiello C; Giavoli C; Giordano M; Guazzarotti L; Klain A; Montini G; Murer L; Parpagnoli M; Pecoraro C; Pesce S; Verrina E
    Front Endocrinol (Lausanne); 2020; 11():587. PubMed ID: 33013690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.